@article{roth:hal-03931293,
TITLE = {Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?},
AUTHOR = {Roth, G.S. and Neuzillet, C. and Sarabi, M. and Edeline, J. and Malka, D and Li{\`e}vre, Astrid},
URL = {https://hal.science/hal-03931293},
JOURNAL = {European Journal of Cancer},
PUBLISHER = {Elsevier},
VOLUME = {179},
PAGES = {1-14},
YEAR = {2023},
MONTH = Jan, DOI = {10.1016/j.ejca.2022.11.006},
KEYWORDS = {Bile tract cancer ; Cholangiocarcinoma ; FGFR2 fusion ; HER2 amplification ; IDH1 mutation ; Molecular profiling ; Personnalized medicine},
PDF = {https://hal.science/hal-03931293/file/Roth%20et%20al.%20-%202022%20-%20Cholangiocarcinoma%20what%20are%20the%20options%20in%20all%20co.pdf},
HAL_ID = {hal-03931293},
HAL_VERSION = {v1},
}